Angiotensin II-induced production of mitochondrial reactive oxygen species: Potential mechanisms and relevance for cardiovascular disease

Antioxidants and Redox Signaling

Volumn 19, Issue 10, 2013, Pages 1085-1094

  Dikalov, Sergey I ^a   Nazarewicz, Rafal R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN II; CANDESARTAN; CYTOCHROME C OXIDASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; LOSARTAN; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SIRTUIN 3; THIOREDOXIN 2;

ADRENERGIC SYSTEM; APOPTOSIS; ATHEROSCLEROSIS; AUTOPHAGY; BIOGENESIS; CELL SURVIVAL; DEPRESSED BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; ENDOPLASMIC RETICULUM; ENDOTHELIAL DYSFUNCTION; ENERGY YIELD; ENZYME ACTIVITY; FIBROSING ALVEOLITIS; FOCAL ADHESION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART INFARCTION; HEART INJURY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; ISCHEMIC PRECONDITIONING; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY STRUCTURE; METABOLIC SYNDROME X; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MITOCHONDRION SWELLING; NECROSIS; NONHUMAN; OXIDATIVE STRESS; PANCREAS INJURY; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESPIRATION CONTROL; RESPIRATORY CHAIN; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES; STRESS FIBER; SYSTOLIC BLOOD PRESSURE; TISSUE DEGENERATION; TRANSGENIC MOUSE; VASCULAR TISSUE;

ANGIOTENSIN II; ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; HYDROGEN PEROXIDE; MITOCHONDRIA; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 84884194246     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4604     Document Type: Review

References (68)

1. Ago T, Kuroda J, Pain J, Fu C, Li H, and Sadoshima J. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res 106: 1253-1264, 2010.
2. Anilkumar N, Weber R, Zhang M, Brewer A, and Shah AM. Nox4 and nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arterioscler Thromb Vasc Biol 28: 1347-1354, 2008.
3. Bell RM, Cave AC, Johar S, Hearse DJ, Shah AM, and Shattock MJ. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J Off Publ Fed Am Soc Exp Biol 19: 2037-2039, 2005.
4. Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, and Remuzzi G. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Investig 119: 524-530, 2009.
5. Block K, Gorin Y, and Abboud HE. Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci U S A 106: 14385-14390, 2009.
6. Brewer AC, Murray TV, Arno M, Zhang M, Anilkumar NP, Mann GE, and Shah AM. Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo. Free Radic Bio Med 51: 205-215, 2011.
7. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625, 2005.
8. Bugger H and Abel ED. Mitochondria in the diabetic heart. Cardiovasc Res 88: 229-240, 2010.
9. Cai H, Li Z, Dikalov S, Holland SM, Hwang J, Jo H, Dudley SC Jr., and Harrison DG. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 277: 48311-48317, 2002.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., and Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama 289: 2560-2572, 2003.
11. Dai DF, Chen T, Szeto H, Nieves-Cintron M, Kutyavin V, Santana LF, and Rabinovitch PS. Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol 58: 73-82, 2011.
12. Dai DF and Rabinovitch P. Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin- II treated mouse hearts. Autophagy 7: 917-918, 2011.
13. de Cavanagh EM, Ferder L, Toblli JE, Piotrkowski B, Stella I, Fraga CG, and Inserra F. Renal mitochondrial impairment is attenuated by AT1 blockade in experimental Type I diabetes. Am J Physiol Heart Circ Physiol 294: H456-H465, 2008.
14. de Cavanagh EM, Inserra F, and Ferder L. Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria? Cardiovasc Res 89: 31-40, 2011.
15. de Cavanagh EM, Piotrkowski B, Basso N, Stella I, Inserra F, Ferder L, and Fraga CG. Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J 17: 1096-1098, 2003.
16. De Cavanagh EM, Toblli JE, Ferder L, Piotrkowski B, Stella I, Fraga CG, and Inserra F. Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats. Cell Mol Biol 51: 573-578, 2005.
17. de Cavanagh EM, Toblli JE, Ferder L, Piotrkowski B, Stella I, and Inserra F. Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine. Am J Physiol Regul Integr Comp Physiol 290: R1616-R1625, 2006.
18. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med 51: 1289-1301, 2011.
19. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, and Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 45: 1340-1351, 2008.
20. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG, and Dikalov SI. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 107: 106-116, 2010.
21. Doughan AK, Harrison DG, and Dikalov SI. Molecular mechanisms of angiotensin II mediated mitochondrial dysfunction. Linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102: 488-496, 2008.
22. Gao L and Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res 82: 9-20, 2009.
23. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
24. Guzik TJ, Chen W, Gongora MC, Guzik B, Lob HE, Mangalat D, Hoch N, Dikalov S, Rudzinski P, Kapelak B, Sadowski J, and Harrison DG. Calcium-dependent NOX5 NADPH oxidase contributes to vascular oxidative stress in human coronar artery disease. J Am Coll Cardiol 52: 1803-1809, 2008.
25. Hanna IR, Taniyama Y, Szocs K, Rocic P, and Griendling KK. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4: 899-914, 2002.
26. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683, 2004.
27. Hingtgen SD, Tian X, Yang J, Dunlay SM, Peek AS, Wu Y, Sharma RV, Engelhardt JF, and Davisson RL. Nox2- containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics 26: 180-191, 2006.
28. Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, and Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 143: 2975-2985, 2002.
29. Infanger DW, Cao X, Butler SD, Burmeister MA, Zhou Y, Stupinski JA, Sharma RV, and Davisson RL. Silencing nox4 in the paraventricular nucleus improves myocardial infarctioninduced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ Res 106: 1763-1774, 2010.
30. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Suzuki T, Maeta H, and Abe Y. Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 45: 860-866, 2005.
31. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, Welch WJ, and Wilcox CS. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 14: 2775-2782, 2003.
32. Krijnen PA, Meischl C, Hack CE, Meijer CJ, Visser CA, Roos D, and Niessen HW. Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol 56: 194-199, 2003.
33. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, and Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci U S A 107: 15565-15570, 2010.
34. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
35. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, and Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redoxsensitive signaling pathways. Circ Res 88: 888-894, 2001.
36. Lavoie JL and Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology 144: 2179-2183, 2003.
37. Lob HE, Marvar PJ, Guzik TJ, Sharma S, McCann LA, Weyand C, Gordon FJ, and Harrison DG. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension 55: 277-283, 6p following 283, 2010.
38. Lob HE, Vinh A, Li L, Blinder Y, Offermanns S, and Harrison DG. Role of vascular extracellular superoxide dismutase in hypertension. Hypertension 58: 232-239, 2011.
39. Looi YH, Grieve DJ, Siva A, Walker SJ, Anilkumar N, Cave AC, Marber M, Monaghan MJ, and Shah AM. Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 51: 319-325, 2008.
40. Lou M, Blume A, Zhao Y, Gohlke P, Deuschl G, Herdegen T, and Culman J. Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat. J Cereb Blood Flow Metab 24: 536-547, 2004.
41. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassegue B, and Griendling KK. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105: 249-259, 2009.
42. Madamanchi NR and Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res 100: 460-473, 2007.
43. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, and Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18: 69-82, 2006.
44. Monteiro P, Duarte AI, Goncalves LM, and Providencia LA. Valsartan improves mitochondrial function in hearts submitted to acute ischemia. Eur J Pharmacol 518: 158-164, 2005.
45. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, Nishida K, Hori M, Mizushima N, and Otsu K. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13: 619-624, 2007.
46. Nishino Y, Miura T, Miki T, Sakamoto J, Nakamura Y, Ikeda Y, Kobayashi H, and Shimamoto K. Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc Res 61: 610-619, 2004.
47. Nistala R, Wei Y, Sowers JR, and Whaley-Connell A. Reninangiotensin- aldosterone system-mediated redox effects in chronic kidney disease. Transl Res 153: 102-113, 2009.
48. Pomerantz BJ, Robinson TN, Heimbach JK, Calkins CM, Miller SA, Banerjee A, and Harken AH. Selective mitochondrial KATP channel opening controls human myocardial preconditioning: too much of a good thing? Surgery 128: 368-373, 2000.
49. Puddu P, Puddu GM, Galletti L, Cravero E, and Muscari A. Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis. Cardiology 103: 137-141, 2005.
50. Quast U, Stephan D, Bieger S, and Russ U. The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium. Diabetes 53 Suppl 3: S156-S164, 2004.
51. Queliconi BB, Wojtovich AP, Nadtochiy SM, Kowaltowski AJ, and Brookes PS. Redox regulation of the mitochondrial K(ATP) channel in cardioprotection. Biochim Biophys Acta 1813: 1309-1315, 2011.
52. Rodriguez-Iturbe B, Sepassi L, Quiroz Y, Ni Z, Wallace DC, and Vaziri ND. Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence. J Appl Physiol 102: 255-260, 2007.
53. Rodriguez-Pallares J, Rey P, Parga JA, Munoz A, Guerra MJ, and Labandeira-Garcia JL. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPHderived ROS. Neurobiol Dis 31: 58-73, 2008.
54. Rossi R, Cioni E, Nuzzo A, Origliani G, and Modena MG. Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women. Diabetes Care 28: 702-707, 2005.
55. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91: 406-413, 2002.
56. Silberman GA, Fan TH, Liu H, Jiao Z, Xiao HD, Lovelock JD, Boulden BM, Widder J, Fredd S, Bernstein KE, Wolska BM, Dikalov S, Harrison DG, and Dudley SC Jr. Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation 121: 519-528, 2010.
57. Stanley BA, Sivakumaran V, Shi S, MacDonald I, Lloyd D, Watson WH, Aon MA, and Paolocci N. Thioredoxin reductase 2 is essential for keeping low levels of H2O2 emission from isolated heart mitochondria. J Biol Chem 286: 33669- 33677, 2011.
58. Sun L, Xiao L, Nie J, Liu FY, Ling GH, Zhu XJ, Tang WB, Chen WC, Xia YC, Zhan M, Ma MM, Peng YM, Liu H, Liu YH, and Kanwar YS. p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway. Am J Physiol Renal Physiol 299: F1014-F1025, 2010.
59. Takac I, Schroder K, Zhang L, Lardy B, Anilkumar N, Lambeth JD, Shah AM, Morel F, and Brandes RP. The E-loop Is Involved in Hydrogen Peroxide Formation by the NADPH Oxidase Nox4. J Biol Chem 286: 13304-13313, 2011.
60. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, and Alexander RW. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 489-495, 2001.
61. Wang Y and Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 164: 2126-2134, 2004.
62. Whaley-Connell A, Habibi J, Nistala R, Cooper SA, Karuparthi PR, Hayden MR, Rehmer N, DeMarco VG, Andresen BT, Wei Y, Ferrario C, and Sowers JR. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Hypertension 51: 474-480, 2008.
63. Widder JD, Fraccarollo D, Galuppo P, Hansen JM, Jones DP, Ertl G, and Bauersachs J. Attenuation of Angiotensin IIInduced Vascular Dysfunction and Hypertension by Overexpression of Thioredoxin 2. Hypertension 54: 338-344, 2009.
64. Zhang M, Brewer AC, Schroder K, Santos CX, Grieve DJ, Wang M, Anilkumar N, Yu B, Dong X, Walker SJ, Brandes RP, and Shah AM. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci U S A 107: 18121- 18126, 2010.
65. Zhao Y, McLaughlinD, Robinson E, Harvey AP,HookhamMB, Shah AM, McDermott BJ, and Grieve DJ. Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy. Cancer Res 70: 9287-9297, 2010.
66. Zimmerman MC. Angiotensin II and angiotensin-1-7 redox signaling in the central nervous system. Curr Opin Pharmacol 11: 138-143, 2011.
67. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, and Davisson RL. Superoxide Mediates the Actions of Angiotensin II in the Central Nervous System. Circ Res 91: 1038-1045, 2002.
68. Zimmerman MC, Sharma RV, and Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 45: 717-723, 2005.